Please Wait.....
Report
Global Veterinary Vaccines Market Report and Forecast 2023-2031
Market Report I 2023-05-16 I 147 Pages I EMR Inc.
Global Veterinary Vaccines Market Report and Forecast 2023-2031
Global Veterinary Vaccines Market Outlook
The global veterinary vaccines market value was USD 10.1 billion in 2022, driven by the rising prevalence of zoonotic diseases structure across the globe. The market size is anticipated to grow at a CAGR of 6.2% during the forecast period of 2023-2031 to achieve a value of USD 17.4 billion by 2031.
Veterinary Vaccines Introduction
Veterinary vaccines are essential for preventing and controlling infectious diseases in animals, ensuring animal health and welfare, and safeguarding public health. These vaccines play a crucial role in maintaining the health of livestock, poultry, and companion animals by stimulating their immune systems to produce a specific immune response against pathogens. Veterinary vaccines also help improve animal productivity and reduce the use of antibiotics, contributing to the fight against antimicrobial resistance.
The global veterinary vaccines market is experiencing significant growth due to factors such as the increasing demand for livestock products, the rising prevalence of zoonotic diseases, growing pet ownership, and the need for effective disease prevention in animals. Technological advancements in vaccine development, such as recombinant vaccines and DNA vaccines, are further driving the market. Additionally, government initiatives and investments in veterinary healthcare and research are contributing to the market's expansion.
Veterinary Vaccines Market Scenario
The global veterinary vaccines market is poised for significant growth as the demand for effective disease prevention in animals continues to rise. Factors such as the increasing demand for livestock products, the rising prevalence of zoonotic diseases, and technological advancements in vaccine development contribute to the market's expansion. The market is characterized by regional dynamics shaped by veterinary healthcare infrastructure, government support, and investment in research and development. However, challenges such as the high cost of vaccine development, limited access to vaccines in low- and middle-income countries, and the need for maintaining cold chain logistics may impact market growth.
North America: The largest market for veterinary vaccines, driven by factors such as advanced veterinary healthcare infrastructure, the presence of leading vaccine manufacturers, and a high focus on animal health and welfare.
Europe: The second-largest market, with increasing demand for veterinary vaccines due to a growing emphasis on food safety, animal welfare, and government support for research and development.
Asia-Pacific: Expected to witness the highest growth rate due to factors such as a rapidly growing livestock industry, increasing pet ownership, and growing investments in veterinary healthcare infrastructure and research.
Veterinary Vaccines Market Segmentations
Market Breakup by Type
- Live Attenuated Vaccines
- Inactivated Vaccines
- Toxoid Vaccines
- DNA Vaccines
- Recombinant Vaccines
- Other Vaccines
Market Breakup by Animal Type
- Porcine
- Poultry
- Livestock
- Bovine
- Small Ruminant
- Companion Animal
- Canine
- Feline
- Aquaculture
- Others
Market Breakup by Route of Administration
- Oral
- Parenteral
- Topical
Market Breakup by End User
- Veterinary Hospitals
- Veterinary Clinics
- Poultry Farms
- Animal Farms
- Others
Market Breakup by Distribution Channel
- Online Stores
- Pharmacies and Drug Stores
- Others
Market Breakup by Region
- North America
- United States of America
- Canada
- Europe
- United Kingdom
- Germany
- France
- Italy
- Others
- Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
- Latin America
- Brazil
- Argentina
- Mexico
- Others
- Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Key Trends in the Veterinary Vaccines Market
Some key trends of the market are as follows:
- Increasing demand for livestock products: The rising demand for livestock products, such as meat, milk, and eggs, is driving the need for effective vaccines to ensure the health and productivity of livestock animals.
- Growing prevalence of zoonotic diseases: The increasing occurrence of zoonotic diseases, which can be transmitted between animals and humans, is prompting the adoption of veterinary vaccines to protect public health.
- Technological advancements in vaccine development: The introduction of advanced vaccine technologies, such as recombinant and DNA vaccines, has improved the efficacy and safety of veterinary vaccines, leading to increased adoption.
Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the Veterinary Vaccines market are as follows:
- Bayer AG
- Sanofi
- Pfizer Inc.
- GSK plc.
- Merck & Co., Inc.
- Ceva
- Cargill, Incorporated
- Boehringer Ingelheim International GmbH.
- Takeda Pharmaceutical Company Limited
- Zoetis
- Dechra Pharmaceuticals PLC
- Hester Biosciences Limited.
- Elanco
- Phibro Animal Health Corporation
- Indovax
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Veterinary Vaccines Market Overview
3.1 Global Veterinary Vaccines Market Historical Value (2016-2022)
3.2 Global Veterinary Vaccines Market Forecast Value (2023-2031)
4 Global Veterinary Vaccines Market Landscape
4.1 Global Veterinary Vaccines Developers Landscape
4.1.0 Analysis by Year of Establishment
4.1.1 Analysis by Company Size
4.1.2 Analysis by Region
4.2 Global Veterinary Vaccines Product Landscape
4.2.0 Analysis by Type
4.2.1 Analysis by Animal Type
4.2.2 Analysis by End User
5 Global Veterinary Vaccines Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter's Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Veterinary Vaccines Market Segmentation
6.1 Global Veterinary Vaccines Market by Type
6.1.0 Market Overview
6.1.1 Live Attenuated Vaccines
6.1.2 Inactivated Vaccines
6.1.3 Toxoid Vaccines
6.1.4 DNA Vaccines
6.1.5 Recombinant Vaccines
6.1.6 Other Vaccines
6.2 Global Veterinary Vaccines Market by Animal Type
6.2.0 Market Overview
6.2.1 Porcine
6.2.2 Poultry
6.2.3 Livestock
6.2.3.1 Bovine
6.2.3.2 Small Ruminant
6.2.4 Companion Animal
6.2.4.1 Canine
6.2.4.2 Feline
6.2.5 Aquaculture
6.2.6 Others
6.3 Global Veterinary Vaccines Market by Route of Administration
6.3.0 Market Overview
6.3.1 Oral
6.3.2 Parenteral
6.3.3 Topical
6.4 Global Veterinary Vaccines Market by End User
6.4.0 Market Overview
6.4.1 Veterinary Hospitals
6.4.2 Veterinary Clinics
6.4.3 Poultry Farms
6.4.4 Animal Farms
6.4.5 Others
6.5 Global Veterinary Vaccines Market by Distribution Channel
6.5.0 Market Overview
6.5.1 Online Stores
6.5.2 Pharmacies and Drug Stores
6.5.3 Others
6.6 Global Veterinary Vaccines Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Veterinary Vaccines Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Veterinary Vaccines Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Veterinary Vaccines Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Veterinary Vaccines Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Veterinary Vaccines Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Clinical Trials Analysis
14.1 Analysis by Trial Registration Year
14.2 Analysis by Trial Status
14.3 Analysis by Trial Phase
14.4 Analysis by Therapeutic Area
14.5 Analysis by Geography
15 Funding Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Regulatory Framework
17.1 Regulatory Overview
17.1.0 US FDA
17.1.1 EU EMA
17.1.2 INDIA CDSCO
17.1.3 JAPAN PMDA
17.1.4 Others
18 Supplier Landscape
18.1 Bayer AG
18.1.0 Financial Analysis
18.1.1 Product Portfolio
18.1.2 Demographic Reach and Achievements
18.1.3 Mergers and Acquisitions
18.1.4 Certifications
18.2 Sanofi
18.2.0 Financial Analysis
18.2.1 Product Portfolio
18.2.2 Demographic Reach and Achievements
18.2.3 Mergers and Acquisitions
18.2.4 Certifications
18.3 Pfizer Inc.
18.3.0 Financial Analysis
18.3.1 Product Portfolio
18.3.2 Demographic Reach and Achievements
18.3.3 Mergers and Acquisitions
18.3.4 Certifications
18.4 GSK plc.
18.4.0 Financial Analysis
18.4.1 Product Portfolio
18.4.2 Demographic Reach and Achievements
18.4.3 Mergers and Acquisitions
18.4.4 Certifications
18.5 Merck & Co., Inc.
18.5.0 Financial Analysis
18.5.1 Product Portfolio
18.5.2 Demographic Reach and Achievements
18.5.3 Mergers and Acquisitions
18.5.4 Certifications
18.6 Ceva
18.6.0 Financial Analysis
18.6.1 Product Portfolio
18.6.2 Demographic Reach and Achievements
18.6.3 Mergers and Acquisitions
18.6.4 Certifications
18.7 Cargill, Incorporated
18.7.0 Financial Analysis
18.7.1 Product Portfolio
18.7.2 Demographic Reach and Achievements
18.7.3 Mergers and Acquisitions
18.7.4 Certifications
18.8 Boehringer Ingelheim International GmbH.
18.8.0 Financial Analysis
18.8.1 Product Portfolio
18.8.2 Demographic Reach and Achievements
18.8.3 Mergers and Acquisitions
18.8.4 Certifications
18.9 Takeda Pharmaceutical Company Limited
18.9.0 Financial Analysis
18.9.1 Product Portfolio
18.9.2 Demographic Reach and Achievements
18.9.3 Mergers and Acquisitions
18.9.4 Certifications
18.10 Zoetis
18.10.0 Financial Analysis
18.10.1 Product Portfolio
18.10.2 Demographic Reach and Achievements
18.10.3 Mergers and Acquisitions
18.10.4 Certifications
18.11 Dechra Pharmaceuticals PLC
18.11.0 Financial Analysis
18.11.1 Product Portfolio
18.11.2 Demographic Reach and Achievements
18.11.3 Mergers and Acquisitions
18.11.4 Certifications
18.12 Hester Biosciences Limited.
18.12.0 Financial Analysis
18.12.1 Product Portfolio
18.12.2 Demographic Reach and Achievements
18.12.3 Mergers and Acquisitions
18.12.4 Certifications
18.13 Elanco
18.13.0 Financial Analysis
18.13.1 Product Portfolio
18.13.2 Demographic Reach and Achievements
18.13.3 Mergers and Acquisitions
18.13.4 Certifications
18.14 Phibro Animal Health Corporation
18.14.0 Financial Analysis
18.14.1 Product Portfolio
18.14.2 Demographic Reach and Achievements
18.14.3 Mergers and Acquisitions
18.14.4 Certifications
18.15 Indovax
18.15.0 Financial Analysis
18.15.1 Product Portfolio
18.15.2 Demographic Reach and Achievements
18.15.3 Mergers and Acquisitions
18.15.4 Certifications
19 Global Veterinary Vaccines Market - Distribution Model (Additional Insight)
19.1 Overview
19.2 Potential Distributors
19.3 Key Parameters for Distribution Partner Assessment
20 Key Opinion Leaders (KOL) Insights (Additional Insight)
21 Company Competitiveness Analysis (Additional Insight)
21.1 Very Small Companies
21.2 Small Companies
21.3 Mid-Sized Companies
21.4 Large Companies
21.5 Very Large Companies
22 Payment Methods (Additional Insight)
22.1 Government Funded
22.2 Private Insurance
22.3 Out-of-Pocket
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security